Table_8_Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma.XLSX (74.88 kB)
Download file

Table_8_Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma.XLSX

Download (74.88 kB)
dataset
posted on 01.07.2021, 04:55 authored by Deyao Shi, Shidai Mu, Feifei Pu, Binlong Zhong, Binwu Hu, Jianxiang Liu, Tongchuan He, Zhicai Zhang, Zengwu Shao

Due to the rarity and heterogeneity, it is challenging to explore and develop new therapeutic targets for patients with sarcoma. Recently, immune cell infiltration in the tumor microenvironment (TME) was widely studied, which provided a novel potential approach for cancer treatment. The competing endogenous RNA (ceRNA) regulatory network has been reported as a critical molecular mechanism of tumor development. However, the role of the ceRNA regulatory network in the TME of sarcoma remains unclear. In this study, gene expression data and clinical information were obtained from The Cancer Genome Atlas (TCGA) sarcoma datasets, and an immune infiltration-related ceRNA network was constructed, which comprised 14 lncRNAs, 13 miRNAs, and 23 mRNAs. Afterward, we constructed an immune infiltration-related risk score model based on the expression of IRF1, MFNG, hsa-miR-940, and hsa-miR-378a-5p, presenting a promising performance in predicting the prognosis of patients with sarcoma.

History

References